What is the dosage and treatment regimen for Albendazole (albendazole) in treating parasitic worm infestations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albendazole Dosing and Treatment Regimens for Parasitic Worm Infestations

Albendazole 400 mg as a single oral dose is the standard treatment for most common intestinal nematode infections including hookworm, roundworm (Ascaris), and pinworm (Enterobius), with the medication taken with food to enhance absorption. 1, 2

Standard Dosing by Infection Type

Single-Dose Regimens (400 mg)

  • Hookworm (Ancylostoma/Necator): 400 mg single dose achieves 90-100% cure rates 1, 3
  • Roundworm (Ascaris lumbricoides): 400 mg single dose with 100% efficacy 1, 3, 4
  • Pinworm (Enterobius vermicularis): 400 mg single dose, repeated in 2 weeks to eliminate newly hatched worms 1, 5
  • Whipworm (Trichuris trichiura): 400 mg single dose, though higher doses (600 mg) may improve efficacy for this organism 3

Weight-Based Dosing

  • Patients ≥60 kg: 400 mg twice daily with meals 2
  • Patients <60 kg: 15 mg/kg/day divided into two doses with meals (maximum 800 mg/day) 2

Extended Treatment Regimens

Hydatid Disease (Echinococcosis)

  • Dosing: 400 mg twice daily (or 15 mg/kg/day if <60 kg) 2
  • Duration: 28-day treatment cycle followed by 14-day drug-free interval, repeated for 3 total cycles 2
  • Cyst size considerations: Albendazole alone for cysts <5 cm; combination with praziquantel for larger cysts 1
  • Long-term therapy: Life-long courses may be required for E. multilocularis with frequent recurrence 1

Neurocysticercosis

  • Dosing: 400 mg twice daily (or 15 mg/kg/day if <60 kg) 2
  • Duration: 8-30 days depending on disease severity and location 2
  • Parenchymal disease (1-2 cysts): Albendazole plus corticosteroids 1
  • Parenchymal disease (>2 cysts): Combination albendazole plus praziquantel plus corticosteroids 1
  • Subarachnoid cysts: Prolonged albendazole (15 mg/kg/day for months) or combination with praziquantel 50 mg/kg/day 1

Trichinellosis (Trichinella)

  • Mild disease: 400 mg once daily for 3 days 1
  • Severe disease: Extended courses with corticosteroids 1

Critical Administration Requirements

Food Requirement

Albendazole must be taken with food, particularly fatty meals, to enhance absorption by up to 5-fold. 2 This is essential for achieving therapeutic drug levels, especially for tissue infections.

Tablet Administration

  • Tablets may be crushed or chewed and swallowed with water 2
  • This is particularly useful for pediatric patients or those with swallowing difficulties 2

Empirical Treatment Approach

Asymptomatic Eosinophilia in Travelers

For returning travelers with eosinophilia and negative stool studies, empirical treatment with albendazole 400 mg single dose plus ivermectin 200 μg/kg is recommended to cover prepatent geohelminth infections. 1

  • Repeat treatment at 8 weeks to address schistosomiasis if suspected, as eggs and immature schistosomulae are treatment-resistant 1
  • Exclude Loa loa before ivermectin in patients from endemic regions to prevent severe adverse reactions 1

Mandatory Monitoring Requirements

Hematologic Monitoring

Monitor complete blood counts at the beginning of each 28-day cycle and every 2 weeks during therapy, as fatal bone marrow suppression has been reported. 2

  • Discontinue immediately if clinically significant leukopenia or neutropenia develops 2
  • Risk increases with prolonged therapy (>14-28 days) 1, 6

Hepatic Monitoring

Monitor liver enzymes (transaminases) at the start of each treatment cycle and at least every 2 weeks during therapy. 2

  • Elevations occur in up to 16% of patients on chronic therapy 1
  • Discontinue promptly if significant elevations occur; transaminases typically normalize after cessation 1

Pregnancy Testing

Obtain pregnancy test in all females of reproductive potential before initiating therapy, as albendazole causes fetal harm. 2

Special Clinical Situations

Neurocysticercosis-Specific Precautions

  • Initiate corticosteroids before or concurrent with albendazole to prevent cerebral hypertensive episodes during the first week 2
  • Screen for retinal cysticercosis before treatment, as retinal damage can occur 2
  • Ensure anticonvulsant therapy is optimized, as seizure frequency may transiently increase 1

Pediatric Considerations

  • Children aged >24 months: Standard 400 mg single dose for intestinal nematodes 1, 5
  • Children aged 12-24 months: Discuss with expert before empirical treatment 1
  • Children aged 2-6 years: Dose adjustments for weight-based regimens 5

Drug Interactions Requiring Dose Adjustment

Dexamethasone Co-administration

  • Increases albendazole sulfoxide concentrations by 56% 2
  • This interaction is clinically utilized in neurocysticercosis treatment 2

Praziquantel Co-administration

  • Increases albendazole sulfoxide levels by 50% when taken with food 2
  • Used therapeutically for combination treatment of complex cystic disease 2

Cimetidine Co-administration

  • Doubles albendazole sulfoxide concentrations in bile and cystic fluid 2
  • May enhance efficacy for hepatic hydatid disease 2

Theophylline Monitoring

  • Albendazole induces CYP1A enzymes 2
  • Monitor theophylline levels during and after albendazole treatment 2

Common Pitfalls to Avoid

Inadequate Treatment Duration

  • Single-dose therapy is insufficient for tissue infections (hydatid disease, neurocysticercosis) 2
  • Pinworm requires repeat dosing at 2 weeks due to reinfection from environmental eggs 5

Failure to Provide Adjunctive Therapy

  • Neurocysticercosis requires corticosteroids to prevent inflammatory complications 2
  • Hydatid disease may require surgical intervention for large or complicated cysts 1

Inadequate Monitoring

  • Prolonged therapy (>14 days) without hematologic and hepatic monitoring risks serious toxicity 1, 2, 6
  • Failure to exclude pregnancy before treatment exposes fetus to teratogenic risk 2

Taking Without Food

  • Fasting administration results in inadequate drug absorption and treatment failure 2
  • This is particularly critical for tissue infections requiring sustained therapeutic levels 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Albendazole, an effective single dose, broad spectrum anthelmintic drug.

The American journal of tropical medicine and hygiene, 1983

Guideline

Pinworm Treatment Guidelines for Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.